Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $53.24 ($343K) on 2012-07-16, disclosed to the SEC on 2012-07-18.
Scheduled sale ($343k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.49 | 4,000 | $210K | 61.2% |
| 2 | $53.24 | 2,500 | $133K | 38.8% |
| Total | $52.78 avg | 6,500 | $343K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |